Dr. Marty Makary on estrogen patch shortages and FDA's role
FDA Commissioner Dr. Marty Makary discusses the demand surge and shortages of estrogen patches. He explains the FDA's decision to remove the black box warning, leading to increased demand, and its impact on women's health and menopause.
